Influence of age on the pharmacokinetics of butorphanol. 1988

R Ramsey, and M Higbee, and J Maesner, and J Wood
Department of Pharmacy Practice, University of Utah, Salt Lake City.

Butorphanol kinetics were studied in 8 young (23-34 years of age) and 9 elderly (65-79 years of age) healthy male subjects following a single, intravenous 2-mg dose of butorphanol tartrate. Plasma and blood concentrations collected over 24 h were analyzed by a second antibody radioimmunoassay for unchanged drug. Systemic blood clearance (21.29 +/- 7.18 ml/min/kg), apparent steady-state volume of distribution (9.02 +/- 2.40 liters/kg), distribution half-life (7.67 +/- 4.66 min), and the blood/plasma concentration ratio (1.21 +/- 0.36) in the elderly did not differ from those in the younger subjects. However, the terminal elimination half-life was significantly prolonged in the elderly (5.51 +/- 2.49 versus 3.67 +/- 0.52 h, p less than 0.05). Positive correlations between age and terminal elimination half-life and volume of distribution were noted. Our data suggest that young and old subjects attain similar plasma concentrations after single doses; however, longer dosing intervals may be necessary for multiple dosing in the elderly. The appropriate dosing interval for butorphanol needs to be assessed in elderly patients.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D009019 Morphinans Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS. Morphinan
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002077 Butorphanol A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain. 17-(Cyclobutylmethyl)morphinan-3,14-diol,Apo-Butorphanol,BC-2627,Beforal,Butorphanol Tartrate,Dolorex,Moradol,Stadol,Stadol NS,Torbugesic,BC 2627,BC2627
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

R Ramsey, and M Higbee, and J Maesner, and J Wood
January 1994, European journal of clinical pharmacology,
R Ramsey, and M Higbee, and J Maesner, and J Wood
January 1982, Psychopharmacology,
R Ramsey, and M Higbee, and J Maesner, and J Wood
January 1997, Cancer chemotherapy and pharmacology,
R Ramsey, and M Higbee, and J Maesner, and J Wood
January 1989, Scandinavian journal of infectious diseases. Supplementum,
R Ramsey, and M Higbee, and J Maesner, and J Wood
July 1996, International journal of clinical pharmacology and therapeutics,
R Ramsey, and M Higbee, and J Maesner, and J Wood
December 1991, The American journal of medicine,
R Ramsey, and M Higbee, and J Maesner, and J Wood
October 1991, Pharmacological research,
R Ramsey, and M Higbee, and J Maesner, and J Wood
April 1991, Journal of clinical pharmacology,
R Ramsey, and M Higbee, and J Maesner, and J Wood
April 1979, British journal of clinical pharmacology,
R Ramsey, and M Higbee, and J Maesner, and J Wood
November 1981, British journal of anaesthesia,
Copied contents to your clipboard!